Analysts Set Smith & Nephew plc (NYSE:SNN) PT at $27.50

Smith & Nephew plc (NYSE:SNN) has been given a consensus recommendation of “Hold” by the eight analysts that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $27.50.

SNN has been the topic of a number of research reports. Canaccord Genuity set a $23.00 price objective on Zymeworks and gave the stock a “buy” rating in a report on Friday, May 3rd. Zacks Investment Research downgraded EXACT Sciences from a “hold” rating to a “sell” rating in a report on Tuesday, July 2nd.

Several hedge funds have recently bought and sold shares of the company. Citigroup Inc. grew its stake in Smith & Nephew by 0.5% during the 4th quarter. Citigroup Inc. now owns 52,113 shares of the medical equipment provider’s stock valued at $1,947,000 after purchasing an additional 261 shares in the last quarter. Wetherby Asset Management Inc. grew its stake in Smith & Nephew by 2.1% during the 1st quarter. Wetherby Asset Management Inc. now owns 17,667 shares of the medical equipment provider’s stock valued at $709,000 after purchasing an additional 371 shares in the last quarter. Eagle Asset Management Inc. grew its stake in Smith & Nephew by 2.6% during the 1st quarter. Eagle Asset Management Inc. now owns 16,024 shares of the medical equipment provider’s stock valued at $642,000 after purchasing an additional 401 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its stake in Smith & Nephew by 12.3% during the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 3,789 shares of the medical equipment provider’s stock valued at $152,000 after purchasing an additional 416 shares in the last quarter. Finally, Commonwealth Equity Services LLC grew its stake in Smith & Nephew by 3.8% during the 4th quarter. Commonwealth Equity Services LLC now owns 11,678 shares of the medical equipment provider’s stock valued at $436,000 after purchasing an additional 432 shares in the last quarter. Institutional investors and hedge funds own 8.69% of the company’s stock.

NYSE SNN traded down $0.46 during trading hours on Tuesday, hitting $43.61. 700,568 shares of the company’s stock were exchanged, compared to its average volume of 527,242. The stock has a 50 day simple moving average of $43.22. Smith & Nephew has a 12-month low of $32.22 and a 12-month high of $44.55. The firm has a market capitalization of $19.00 billion, a price-to-earnings ratio of 21.59, a P/E/G ratio of 3.18 and a beta of 0.29. The company has a quick ratio of 1.15, a current ratio of 2.10 and a debt-to-equity ratio of 0.27.

Smith & Nephew Company Profile

Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Recommended Story: What is a capital gains distribution?

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.